Compare RAPT & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPT | KOS |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 475.3M |
| IPO Year | 2019 | 2011 |
| Metric | RAPT | KOS |
|---|---|---|
| Price | $35.21 | $1.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $57.00 | $1.76 |
| AVG Volume (30 Days) | 365.9K | ★ 21.4M |
| Earning Date | 03-05-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,392,234,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.67 | $0.84 |
| 52 Week High | $42.39 | $3.75 |
| Indicator | RAPT | KOS |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 66.16 |
| Support Level | $33.01 | $1.20 |
| Resistance Level | $35.42 | $1.38 |
| Average True Range (ATR) | 2.17 | 0.11 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 83.95 | 82.28 |
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.